Non Executive Director
Mr. George has been the UK Managing Director of GW Pharmaceuticals since March 2017 and also serves as the Company Secretary. GW Pharmaceuticals is a publicly traded biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
Previously, Mr. George was GW Pharmaceutical’s Chief Financial Officer from 2012 until March 2017 and Financial Controller from 2007 to 2012. Before joining GW Pharmaceuticals, Mr. George held several senior finance roles within both public and private companies.
Mr. George holds a BSc. in Biology from Bristol University and is a chartered accountant. He will also serve as Chairman of NuCana’s Audit Committee.